Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
3.640
-0.030 (-0.82%)
At close: Sep 16, 2026, 4:00 PM EDT
3.630
-0.010 (-0.27%)
After-hours: Sep 16, 2026, 4:35 PM EDT

Bicycle Therapeutics Revenue

Bicycle Therapeutics had revenue of $629.00K in the quarter ending June 30, 2026, a decrease of -78.46%. This brings the company's revenue in the last twelve months to $61.21M, up 217.44% year-over-year. In the year 2025, Bicycle Therapeutics had annual revenue of $72.59M with 105.77% growth.

Revenue (ttm)
$61.21M
Revenue Growth
+217.44%
P/S Ratio
4.16
Revenue / Employee
$212,517
Employees
288
Market Cap
254.77M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.59M37.31M105.77%
Dec 31, 202435.28M8.30M30.76%
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 202010.39M-3.41M-24.72%
Dec 31, 201913.80M6.67M93.40%
Dec 31, 20187.14M5.08M246.41%
Dec 31, 20172.06M--
Dec 31, 20160--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MacroGenics175.14M
Invivyd58.37M
Sutro Biopharma45.70M
AC Immune21.67M
Lineage Cell Therapeutics13.08M
Fate Therapeutics6.49M
Camp4 Therapeutics4.22M
YD Bio510.36K
Revenue Rankings